{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:48:14Z","timestamp":1789181294027,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Regenerative medicine using stem cell technology is an emerging field that is currently tested for inborn and acquired liver diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective.<\/jats:title>\n            <jats:p>This phase I\/II prospective, open label, multicenter, randomized trial aimed primarily at evaluating the safety of Heterologous Human Adult Liver\u2013derived Progenitor Cells (HepaStem) in pediatric patients with urea cycle disorders (UCDs) or Crigler-Najjar (CN) syndrome 6 months posttransplantation. The secondary objective included the assessment of safety up to 12 months postinfusion and of preliminary efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Fourteen patients with UCDs and 6 with CN syndrome were divided into 3 cohorts by body weight and intraportally infused with 3 doses of HepaStem. Clinical status, portal vein hemodynamics, morphology of the liver, de novo detection of circulating anti\u2013human leukocyte antigen antibodies, and clinically significant adverse events (AEs) and serious adverse events to infusion were evaluated by using an intent-to-treat analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The overall safety of HepaStem was confirmed. For the entire study period, patient-month incidence rate was 1.76 for the AEs and 0.21 for the serious adverse events, of which 38% occurred within 1 month postinfusion. There was a trend of higher events in UCD as compared with CN patients. Segmental left portal vein thrombosis occurred in 1 patient and intraluminal local transient thrombus in a second patient. The other AEs were in line with expectations for catheter placement, cell infusion, concomitant medications, age, and underlying diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>This study led to European clinical trial authorization for a phase II study in a homogeneous patient cohort, with repeated infusions and intermediate doses.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002605","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T21:06:32Z","timestamp":1551387992000},"page":"1903-1915","source":"Crossref","is-referenced-by-count":59,"title":["Phase I\/II Trial of Liver\u2013derived Mesenchymal Stem Cells in Pediatric Liver\u2013based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver\u2013derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients"],"prefix":"10.1097","volume":"103","author":[{"given":"Fran\u00e7oise","family":"Smets","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Paediatric Gastroenterology and Hepatology Unit, Cliniques Universitaires St Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dries","family":"Dobbelaere","sequence":"additional","affiliation":[{"name":"Medical Reference Center for Inherited Metabolic Diseases, University Children\u2019s Hospital Jeanne de Flandre and RADEME Research Team for Rare Metabolic and Developmental Diseases, EA 7364, University Lille 2, CHRU Lille, Lille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"McKiernan","sequence":"additional","affiliation":[{"name":"Liver Unit, Birmingham Children\u2019s Hospital, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dionisi-Vici","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Gastroenterology and Nutrition, Ospedale Pediatrico Bambino Ges\u00f9 di Roma, Roma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brou\u00e9","sequence":"additional","affiliation":[{"name":"H\u00e9patologie p\u00e9diatrique et maladies h\u00e9r\u00e9ditaires du m\u00e9tabolisme, Centre de comp\u00e9tences maladies h\u00e9r\u00e9ditaires du m\u00e9tabolisme, H\u00f4pital des enfants, CHU Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jacquemin","sequence":"additional","affiliation":[{"name":"Pediatric Hepatology and Liver Transplantation Unit, Reference Centre for Rare Liver Diseases, CHU Bic\u00eatre, Assistance Publique, H\u00f4pitaux de Paris, DHU Hepatinov, INSERM 1174, University Paris Sud, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Lopes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Gastroenterology Unit, Medical Faculty of Lisbon, University Hospital Santa Maria, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Hospital Pedi\u00e1trico de Coimbra, Centro Hospitalar da Universidade de Coimbra, Coimbra, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Mandel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Metabolic Unit, Rambam Medical Center, Meyer Children\u2019s Hospital, Haifa, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pawlowska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutritional Disorders, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kami\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutritional Disorders, The Children\u2019s Memorial Health Institute, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Shteyer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hadassah Ein-Kerem Medical Center, Jerusalem, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Torre","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Gastroenterology and Nutrition, Ospedale Pediatrico Bambino Ges\u00f9 di Roma, Roma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Liver Transplantation Unit, Institute of Gastroenterology, Schneider Children\u2019s Medical Center of Israel, Petach Tikva, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Eyskens","sequence":"additional","affiliation":[{"name":"Paediatric department, Universitair Ziekenhuis Antwerpen, Edegem, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Clapuyt","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gissen","sequence":"additional","affiliation":[{"name":"GOSH UCL Biomedical Center, UCL Great Ormond Street Institute of Child Health, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Pariente","sequence":"additional","affiliation":[{"name":"Department of Radiology, CHU Bic\u00eatre, Le Kremlin Bic\u00eatre, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grunewald","sequence":"additional","affiliation":[{"name":"Centre for Inborn Errors of Metabolism, Great Ormond Street Hospital and Institute of Child Health, UCL, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Yudkoff","sequence":"additional","affiliation":[{"name":"Mass Spectroscopy Center, The Children\u2019s Hospital of Philadelphia, Philadelphia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mercedes","family":"Binda","sequence":"additional","affiliation":[{"name":"Promethera Biosciences, Mont-Saint-Guibert, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Najimi","sequence":"additional","affiliation":[{"name":"Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain, Brussels, Belgium."},{"name":"Promethera Biosciences, Mont-Saint-Guibert, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Belmonte","sequence":"additional","affiliation":[{"name":"Promethera Biosciences, Mont-Saint-Guibert, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"de Vos","sequence":"additional","affiliation":[{"name":"Promethera Biosciences, Mont-Saint-Guibert, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Thonnard","sequence":"additional","affiliation":[{"name":"Promethera Biosciences, Mont-Saint-Guibert, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Sokal","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Paediatric Gastroenterology and Hepatology Unit, Cliniques Universitaires St Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium."},{"name":"Promethera Biosciences, Mont-Saint-Guibert, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"R1-20231002","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/TP.0b013e318199936a","article-title":"One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects.","volume":"87","author":"Meyburg","year":"2009","journal-title":"Transplantation"},{"issue":"3","key":"R2-20231002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2796.2012.02574.x","article-title":"Hepatocyte transplantation for inherited metabolic diseases of the liver.","volume":"272","author":"Jorns","year":"2012","journal-title":"J Intern Med"},{"issue":"1","key":"R3-20231002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1399-3046.2007.00788.x","article-title":"Cell transplantation in the treatment of liver diseases.","volume":"12","author":"Smets","year":"2008","journal-title":"Pediatr Transplant"},{"issue":"7","key":"R4-20231002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3727\/000000007783465154","article-title":"Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes?","volume":"16","author":"Najimi","year":"2007","journal-title":"Cell Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/8904_2013_257","article-title":"Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency.","volume":"13","author":"Sokal","year":"2014","journal-title":"JIMD Rep"},{"issue":"4","key":"R6-20231002","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nucmedbio.2014.01.010","article-title":"Biodistribution of adult derived human liver stem cells following intraportal infusion in a 17-year-old patient with glycogenosis type 1A.","volume":"41","author":"Defresne","year":"2014","journal-title":"Nucl Med Biol"},{"issue":"4","key":"R7-20231002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10545-014-9691-x","article-title":"Treating inborn errors of liver metabolism with stem cells: current clinical development.","volume":"37","author":"Sokal","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"22","key":"R8-20231002","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3748\/wjg.14.3464","article-title":"Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.","volume":"14","author":"Lysy","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"9303","key":"R9-20231002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0140-6736(02)07529-3","article-title":"Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.","volume":"359","author":"Muraca","year":"2002","journal-title":"Lancet"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-1-60761-688-7_29","article-title":"Human hepatocyte transplantation.","volume":"640","author":"Dhawan","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"8","key":"R11-20231002","doi-asserted-by":"crossref","first-page":"e42819","DOI":"10.1371\/journal.pone.0042819","article-title":"Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity.","volume":"7","author":"Stephenne","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"R12-20231002","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1053\/j.gastro.2006.01.008","article-title":"Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency.","volume":"130","author":"St\u00e9phenne","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"R13-20231002","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1600-6143.2005.00935.x","article-title":"Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation.","volume":"5","author":"St\u00e9phenne","year":"2005","journal-title":"Am J Transplant"},{"issue":"4","key":"R14-20231002","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/01.TP.0000077420.81365.53","article-title":"Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up.","volume":"76","author":"Sokal","year":"2003","journal-title":"Transplantation"},{"issue":"7","key":"R16-20231002","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"R17-20231002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C.","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"6","key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"R19-20231002","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"R20-20231002","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/03014460.2013.807878","article-title":"An estimation of the number of cells in the human body.","volume":"40","author":"Bianconi","year":"2013","journal-title":"Ann Hum Biol"},{"issue":"8","key":"R21-20231002","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.tiv.2006.06.003","article-title":"Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements.","volume":"20","author":"Sohlenius-Sternbeck","year":"2006","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"R22-20231002","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2125.2003.01881.x","article-title":"Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver.","volume":"56","author":"Wilson","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"R23-20231002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s001090100260","article-title":"Hepatocyte transplantation: clinical and experimental application.","volume":"79","author":"Ohashi","year":"2001","journal-title":"J Mol Med (Berl)"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders.","volume":"7","author":"H\u00e4berle","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"R25-20231002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/lt.23583","article-title":"Management and long-term consequences of portal vein thrombosis after liver transplantation in children.","volume":"19","author":"Jensen","year":"2013","journal-title":"Liver Transpl"},{"issue":"10","key":"R26-20231002","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/j.1600-6143.2008.02360.x","article-title":"Portal vein complications in pediatric living donor liver transplantation using left-side grafts.","volume":"8","author":"Ueda","year":"2008","journal-title":"Am J Transplant"},{"issue":"6","key":"R27-20231002","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1432-2277.2005.00127.x","article-title":"Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient.","volume":"18","author":"Baccarani","year":"2005","journal-title":"Transpl Int"},{"issue":"3","key":"R28-20231002","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood-2007-10-117051","article-title":"The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.","volume":"112","author":"Gerber","year":"2008","journal-title":"Blood"},{"issue":"9","key":"R29-20231002","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/lt.20228","article-title":"Permanent access to the portal system for cellular transplantation using an implantable port device.","volume":"10","author":"Darwish","year":"2004","journal-title":"Liver Transpl"},{"issue":"9","key":"R30-20231002","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"issue":"7","key":"R31-20231002","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"issue":"19","key":"R32-20231002","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua.","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"5","key":"R33-20231002","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.coi.2005.07.018","article-title":"Humoral theory of transplantation: further evidence.","volume":"17","author":"Terasaki","year":"2005","journal-title":"Curr Opin Immunol"},{"issue":"9863","key":"R34-20231002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study.","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"R35-20231002","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3727\/096368913X666421","article-title":"Adult human hepatocytes promote CD4(+) T-cell hyporesponsiveness via interleukin-10-producing allogeneic dendritic cells.","volume":"23","author":"Sana","year":"2014","journal-title":"Cell Transplant"},{"issue":"2","key":"R36-20231002","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcyt.2014.10.001","article-title":"Influence of inflammation on the immunological profile of adult-derived human liver mesenchymal stromal cells and stellate cells.","volume":"17","author":"Raicevic","year":"2015","journal-title":"Cytotherapy"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"9302537","DOI":"10.1155\/2016\/9302537","article-title":"Comprehensive screening of cell surface markers expressed by adult-derived human liver stem\/progenitor cells harvested at passage 5: potential implications for engraftment.","volume":"2016","author":"Dollet","year":"2016","journal-title":"Stem Cells Int"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"2679518","DOI":"10.1155\/2017\/2679518","article-title":"Immunoprofiling of adult-derived human liver stem\/progenitor cells: impact of hepatogenic differentiation and inflammation.","volume":"2017","author":"El-Kehdy","year":"2017","journal-title":"Stem Cells Int"},{"issue":"7","key":"R39-20231002","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1097\/TP.0000000000000796","article-title":"Donor-specific HLA antibodies are associated with late allograft dysfunction after pediatric liver transplantation.","volume":"99","author":"Wozniak","year":"2015","journal-title":"Transplantation"},{"issue":"9","key":"R40-20231002","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1097\/TP.0000000000000638","article-title":"Long-term clinical relevance of de novo donor-specific antibodies after pediatric liver transplantation.","volume":"99","author":"Grabhorn","year":"2015","journal-title":"Transplantation"},{"issue":"2","key":"R41-20231002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2012.06.065","article-title":"Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.","volume":"162","author":"Ah Mew","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"R42-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2015.11.007","article-title":"In vivo monitoring of urea cycle activity with (13)C-acetate as a tracer of ureagenesis.","volume":"117","author":"Opladen","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"2","key":"R43-20231002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1203\/PDR.0b013e318179454b","article-title":"N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers.","volume":"64","author":"Tuchman","year":"2008","journal-title":"Pediatr Res"},{"issue":"Suppl 1)","key":"R44-20231002","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.ymgme.2010.02.017","article-title":"Measuring in vivo ureagenesis with stable isotopes.","volume":"100","author":"Yudkoff","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"4","key":"R45-20231002","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.2013-1451","article-title":"Medication adherence and health care utilization in pediatric chronic illness: a systematic review.","volume":"132","author":"McGrady","year":"2013","journal-title":"Pediatrics"},{"issue":"9","key":"R46-20231002","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/sctm.17-0031","article-title":"Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events.","volume":"6","author":"Toyserkani","year":"2017","journal-title":"Stem Cells Transl Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:20:30Z","timestamp":1696224030000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000002605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002605","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}